CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Placebo-controlled, Double-blind, Parallel Study to Determine the Effect of Farlong® NotoGinseng™ (Farlong® Ginseng Plus®) on Cholesterol and Blood Pressure

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04069715
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:10.745012+00:00
Published At: 2020-12-30T00:00:00+00:00
Record Updated At: 2021-05-17
Results Posted At: 2020-12-30
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hyperlipidemias", "Hypertension"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-05-17"
protocolSection.identificationModule.nctId: "NCT04069715"
protocolSection.identificationModule.officialTitle: "A Randomized, Placebo-controlled, Double-blind, Parallel Study to Determine the Effect of Farlong\u00ae NotoGinseng\u2122 (Farlong\u00ae Ginseng Plus\u00ae) on Cholesterol and Blood Pressure"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2020-12-30"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.